Use and Acceptability of HIV Self-Testing Among First-Time Testers at Risk for HIV in Senegal.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Springer Science + Business Media Country of Publication: United States NLM ID: 9712133 Publication Model: Print Cited Medium: Internet ISSN: 1573-3254 (Electronic) Linking ISSN: 10907165 NLM ISO Abbreviation: AIDS Behav Subsets: MEDLINE
    • Publication Information:
      Publication: 2005- : New York, NY : Springer Science + Business Media
      Original Publication: New York, NY : Plenum Press, 1997-
    • Subject Terms:
      Reagent Kits, Diagnostic*; HIV Infections/*diagnosis ; Mass Screening/*statistics & numerical data ; Sex Workers/*statistics & numerical data ; Sexual and Gender Minorities/*statistics & numerical data; Adult ; Diagnostic Self Evaluation ; Female ; HIV Infections/epidemiology ; Humans ; Male ; Mass Screening/methods ; Pilot Projects ; Senegal ; Serologic Tests ; Sexual Behavior ; Social Stigma ; Surveys and Questionnaires
    • Abstract:
      HIV Self-Testing (HIVST) aims to increase HIV testing coverage and can facilitate reaching the UNAIDS 90-90-90 targets. In Senegal, key populations bear a disproportionate burden of HIV and report limited uptake of HIV testing given pervasive stigma and criminalization. In these contexts, HIVST may represent a complementary approach to reach populations reporting barriers to engagement with existing and routine HIV testing services. In this study, 1839 HIVST kits were distributed in Senegal, with 1149 individuals participating in a pre-test questionnaire and 817 participating in a post-test questionnaire. Overall, 46.9% (536/1144) were first-time testers and 26.2% (300/1144) had tested within the last year; 94.3% (768/814) reported using the HIVST, and 2.9% (19/651) reported a reactive result which was associated with first-time testers (p = 0.024). HIVST represents an approach that reached first-time testers and those who had not tested recently. Implementation indicators suggest the importance of leveraging existing community structures and programs for distribution.
    • References:
      JMIR Public Health Surveill. 2017 Oct 20;3(4):e72. (PMID: 29054832)
      J Acquir Immune Defic Syndr. 2017 Jan 1;74 Suppl 1:S52-S59. (PMID: 27930612)
      N Engl J Med. 2010 Dec 30;363(27):2587-99. (PMID: 21091279)
      AIDS Behav. 2018 Feb;22(2):560-568. (PMID: 28699017)
      N Engl J Med. 2015 Aug 27;373(9):795-807. (PMID: 26192873)
      J Infect Dis. 2015 Aug 15;212(4):570-7. (PMID: 25767214)
      Syst Rev. 2018 Apr 25;7(1):66. (PMID: 29695295)
      AIDS Behav. 2014 Jun;18(6):1068-74. (PMID: 24057931)
      AIDS. 2014 Aug 24;28(13):1945-56. (PMID: 24845154)
      AIDS Behav. 2018 Feb;22(2):497-512. (PMID: 28155039)
      AIDS Behav. 2013 Jan;17(1):86-93. (PMID: 23142855)
      J Int AIDS Soc. 2017 Apr 25;20(1):21796. (PMID: 28453242)
      Curr Opin HIV AIDS. 2014 Mar;9(2):156-67. (PMID: 24445371)
      Bull World Health Organ. 2015 May 1;93(5):287-287A. (PMID: 26229196)
      J Acquir Immune Defic Syndr. 2013 Jun 1;63 Suppl 1:S102-7. (PMID: 23673879)
      Cult Health Sex. 2017 Jan;19(1):50-63. (PMID: 27263324)
      PLoS Med. 2011 Oct;8(10):e1001102. (PMID: 21990966)
      PLoS Med. 2015 Sep 08;12(9):e1001873. (PMID: 26348035)
      Lancet. 2016 Jan 2;387(10013):53-60. (PMID: 26364263)
      Lancet HIV. 2017 Jun;4(6):e241-e250. (PMID: 28219619)
      J Acquir Immune Defic Syndr. 2016 May 1;72(1):79-86. (PMID: 26745827)
      N Engl J Med. 2011 Aug 11;365(6):493-505. (PMID: 21767103)
      PLoS Med. 2016 Nov 8;13(11):e1002166. (PMID: 27824882)
      AIDS. 2018 Sep 10;32(14):2043-2049. (PMID: 29894386)
      AIDS. 2014 Mar;28 Suppl 2:S105-18. (PMID: 24849469)
      South Afr J HIV Med. 2017 Sep 22;18(1):775. (PMID: 29568643)
      J Acquir Immune Defic Syndr. 2018 Mar 1;77(3):279-287. (PMID: 29210826)
      JMIR Mhealth Uhealth. 2017 Mar 09;5(3):e26. (PMID: 28279949)
      AIDS Behav. 2012 Apr;16(3):608-17. (PMID: 21390540)
      Int J STD AIDS. 2011 Dec;22(12):709-13. (PMID: 22174050)
      PLoS One. 2017 Nov 17;12(11):e0187998. (PMID: 29149194)
      PLoS Med. 2017 Nov 21;14(11):e1002442. (PMID: 29161260)
    • Grant Information:
      P30 AI094189 United States AI NIAID NIH HHS; T32 AI102623 United States AI NIAID NIH HHS; AID-OAA-14-00060 United States Agency for International Development
    • Contributed Indexing:
      Keywords: HIV; Key populations; Self-Testing; Senegal; Sub-Saharan Africa
    • Accession Number:
      0 (Reagent Kits, Diagnostic)
    • Publication Date:
      Date Created: 20190615 Date Completed: 20191028 Latest Revision: 20220425
    • Publication Date:
      20231215
    • Accession Number:
      PMC6773816
    • Accession Number:
      10.1007/s10461-019-02552-2
    • Accession Number:
      31197701